Gastrointestinal Infection Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has conducted a thorough analysis of the Gastrointestinal Infection Testing Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Gastrointestinal Infection Testing Market spanning from 2024 to 2031.

The Global Gastrointestinal Infection Testing Market is poised for growth, driven by rising cases of digestive disorders. By 2031, it's estimated to reach $513.17 million at a CAGR of 4.9%.

Key Insights:

Gastrointestinal Infection Testing Market Size (2024): US$ 444.56 Mn
Projected Market Value (2031): US$ 513.17 Mn
Global Market Growth Rate (CAGR 2024-2031): 4.9%

Gastrointestinal Infection Testing Market - Report Scope:

The scope of the Gastrointestinal Infection Testing Market report entails a thorough analysis of various factors shaping the industry landscape. This encompasses segmentation based on testing methods, target pathogens, end-user segments, and geographical regions. The report provides insights into market size, historical trends, current dynamics, and future growth prospects within the specified period.

Moreover, it explores key market drivers, challenges, opportunities, and regulatory factors influencing market expansion. Competitive landscape analysis, including profiles of major players, market share assessment, and strategic initiatives, is also included. Additionally, the report delves into emerging trends, technological advancements, and investment prospects in the Gastrointestinal Infection Testing Market. Overall, it aims to offer stakeholders valuable insights to facilitate informed decision-making and capitalize on opportunities in the global Gastrointestinal Infection Testing Market.

Market Growth Drivers:

The growth of the Gastrointestinal Infection Testing Market is propelled by various factors. Firstly, the increasing prevalence of gastrointestinal infections worldwide, attributed to factors such as contaminated food and water, poor sanitation, and the spread of infectious agents, drives the demand for accurate diagnostic testing. Additionally, the rising awareness among healthcare professionals and the general population regarding the importance of early detection and prompt treatment of gastrointestinal infections further fuels market growth.

Furthermore, advancements in diagnostic technologies, such as polymerase chain reaction (PCR), immunoassays, and nucleic acid amplification tests (NAATs), enable rapid and accurate detection of a wide range of pathogens causing gastrointestinal infections, thereby driving market adoption. Moreover, the growing emphasis on preventive healthcare measures and the implementation of stringent food safety regulations by regulatory authorities contribute to the demand for gastrointestinal infection testing.

Additionally, the increasing incidence of travel-related gastrointestinal illnesses and the emergence of drug-resistant pathogens underscore the need for robust diagnostic solutions, driving market growth. Furthermore, the integration of molecular diagnostic techniques with point-of-care testing (POCT) devices facilitates decentralized testing and enables timely diagnosis and management of gastrointestinal infections, thereby boosting market expansion.

Market Restraints:

Despite its promising growth prospects, the Gastrointestinal Infection Testing Market faces certain constraints that may impede its growth. One significant challenge is the limited accessibility to advanced diagnostic testing facilities, particularly in rural and remote areas with inadequate healthcare infrastructure. Additionally, the high cost associated with molecular diagnostic tests and the lack of reimbursement policies for these tests in some regions may hinder market penetration.

Moreover, regulatory complexities and the need for stringent quality assurance measures for diagnostic tests pose challenges for market players seeking regulatory approval for new testing products. Furthermore, concerns regarding the accuracy and reliability of certain diagnostic tests, as well as the potential for false-positive or false-negative results, may deter healthcare providers from adopting these testing solutions.

Furthermore, the COVID-19 pandemic has disrupted healthcare systems globally, leading to delays in routine diagnostic testing and a shift in healthcare priorities, which may temporarily slow down market growth. Addressing these challenges will be essential for overcoming market restraints and unlocking the full potential of the Gastrointestinal Infection Testing Market.

Opportunities:

The Gastrointestinal Infection Testing Market offers several opportunities for growth and innovation. Firstly, the increasing focus on personalized medicine and the development of targeted therapies for gastrointestinal infections create opportunities for the development of companion diagnostic tests to guide treatment decisions and monitor treatment response.

Moreover, the growing adoption of multiplex testing platforms capable of detecting multiple pathogens simultaneously presents opportunities for market players to develop comprehensive diagnostic panels for gastrointestinal infections, thereby improving diagnostic accuracy and efficiency. Additionally, the rising demand for rapid diagnostic tests for point-of-care settings, particularly in resource-limited settings and emergency departments, presents opportunities for the development of user-friendly and cost-effective testing solutions.

Furthermore, advancements in diagnostic technologies, such as microfluidics, biosensors, and artificial intelligence (AI), offer opportunities to develop innovative diagnostic platforms with enhanced sensitivity, specificity, and speed, thereby driving market growth. Moreover, strategic collaborations between diagnostic companies, healthcare providers, and academic institutions for research and development initiatives can facilitate the development of novel diagnostic tests and accelerate market entry.

Key Questions Answered in Report::

What is the current size and growth trajectory of the Gastrointestinal Infection Testing Market?
What are the primary factors driving the growth of the market?
What are the major challenges hindering market expansion?
What opportunities exist for stakeholders in the Gastrointestinal Infection Testing Market?
What are the key trends shaping the market landscape?
What are the regulatory factors impacting the market, and how are they influencing market dynamics?

Competitive Intelligence and Business Strategy

Competitive intelligence plays a vital role in shaping effective business strategies within the Gastrointestinal Infection Testing Market. By closely monitoring competitors' actions, including their product offerings, pricing strategies, distribution channels, and marketing tactics, companies can gain valuable insights into market dynamics and identify opportunities for differentiation and growth.

A robust competitive intelligence framework enables businesses to anticipate market trends, customer preferences, and emerging competitive threats, allowing them to proactively adjust their strategies to stay ahead of the curve. This includes analyzing competitors' strengths and weaknesses to identify areas of competitive advantage and potential vulnerabilities to exploit.

Moreover, competitive intelligence informs strategic decision-making processes, such as product development, market positioning, and expansion efforts. By understanding competitors' market positions and customer perceptions, companies can tailor their offerings to address unmet needs and differentiate themselves in the marketplace effectively.

Furthermore, competitive intelligence informs risk assessment and mitigation strategies, enabling businesses to anticipate potential challenges and develop contingency plans to mitigate their impact. This includes monitoring regulatory developments, intellectual property issues, and geopolitical factors that may affect market dynamics and competitive positioning.

Key Companies Profiled

Becton, Dickinson and Company (BD)
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Luminex Corporation
Hoffmann-La Roche Ltd.
bioMerieux SA
Quidel Corporation
Illumina, Inc.
Seegene Inc
Genetic Signatures

Gastrointestinal Infection Testing Market Categorization

Gastrointestinal Infection Testing Market by End User

Hospitals
Clinics/Medical Centers
Diagnostic Laboratories
Research Institutes

Gastrointestinal Infection Testing Market by Disease Strains

Bacterial Strains
Viral Strains
Parasitic Strains

Gastrointestinal Infection Testing Market by Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA

Product Code: PMRREP17314

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition
2.2. Market Taxonomy

3. Gastrointestinal Infection Testing Market Opportunity Analysis

3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background

4.1. Gastrointestinal Infection Outlook
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
4.3. Key Trends

5. Global Economic Outlook

5.1. Gross Domestic Product by Region & Country, 2006 - 2023
5.2. Healthcare Spending Outlook

6. Key Inclusion

6.1. Disease Epidemiology/Statistics
6.2. Regulatory Scenario
6.3. Pricing Analysis and Forecast

7. Global Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2022-2026, By Region

7.1. Introduction/Key Findings
7.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2019-2023
7.3. Market Size (US$ Mn) Forecast By Region, 2022-2026
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. Asia Pacific Excluding China
- 7.3.5. China
- 7.3.6. Middle East & Africa

8. Global Gastrointestinal Infection Testing Analysis 2019-2023 and Forecast 2022-2026, By Disease Strains, By Product, and By End User

8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains, 2019-2023
- 8.2.1. Bacterial Strain
  - 8.2.1.1. Clostridium difficile
  - 8.2.1.2. E. coli
  - 8.2.1.3. Salmonella
  - 8.2.1.4. Staphylococcus aureus
  - 8.2.1.5. Campylobacter
  - 8.2.1.6. Other Bacterial Strains
- 8.2.2. Viral Strains
  - 8.2.2.1. Adenovirus
  - 8.2.2.2. Enterovirus
  - 8.2.2.3. Norovirus
  - 8.2.2.4. Rotavirus
  - 8.2.2.5. Sapovirus
  - 8.2.2.6. Other Viral Strains
- 8.2.3. Parasitic Strains
  - 8.2.3.1. Cryptosporidium parvum
  - 8.2.3.2. Giardia lamblia
  - 8.2.3.3. Other Parasitic Strains
8.3. Market Size (US$ Mn) Forecast By Product, 2024-2031
8.4. Market Attractiveness Analysis by Disease Strains Type
8.5. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2019-2023
- 8.5.1. Reagent Kits
  - 8.5.1.1. PCR Detection Panels
    - 8.5.1.1.1. Norovirus Detection Panels
    - 8.5.1.1.2. Rotavirus Detection Panels
    - 8.5.1.1.3. Adenovirus Detection Panels
    - 8.5.1.1.4. Sapovirus Detection Panels
    - 8.5.1.1.5. Other Viral Detection Panels
    - 8.5.1.1.6. Parasitic Detection Panels
    - 8.5.1.1.7. Clostridium difficile Detection Panels
    - 8.5.1.1.8. Other Detection Panels
- 8.5.2. Sequencing Kits
- 8.5.3. Equipment
  - 8.5.3.1. Automated PCR Systems
  - 8.5.3.2. Sequencers
8.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
8.7. Market Attractiveness Analysis by Product Type
8.8. Historical Market Size (US$ Mn) Trend Analysis by End User Type, 2019-2023
- 8.8.1. Hospitals
- 8.8.2. Clinics/Medical Centers
- 8.8.3. Diagnostic Laboratories
- 8.8.4. Research Institutes
8.9. Market Size (US$ Mn) Forecast By End User Type, 2024-2031
8.10. Market Attractiveness Analysis by Product Type
8.11. Y-o-Y Growth Analysis by Disease Strains, by Product, and by End User

9. North America Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis by Country, 2019-2023
- 9.2.1. U.S.
- 9.2.2. Canada
9.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
9.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 9.4.1. Bacterial Strain
  - 9.4.1.1. Clostridium difficile
  - 9.4.1.2. E. coli
  - 9.4.1.3. Salmonella
  - 9.4.1.4. Staphylococcus aureus
  - 9.4.1.5. Campylobacter
  - 9.4.1.6. Other Bacterial Strains
- 9.4.2. Viral Strains
  - 9.4.2.1. Adenovirus
  - 9.4.2.2. Enterovirus
  - 9.4.2.3. Norovirus
  - 9.4.2.4. Rotavirus
  - 9.4.2.5. Sapovirus
  - 9.4.2.6. Other Viral Strains
- 9.4.3. Parasitic Strains
  - 9.4.3.1. Cryptosporidium parvum
  - 9.4.3.2. Giardia lamblia
  - 9.4.3.3. Other Parasitic Strains
9.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
9.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 9.6.1. Reagent Kits
  - 9.6.1.1. PCR Detection Panels
    - 9.6.1.1.1. Norovirus Detection Panels
    - 9.6.1.1.2. Rotavirus Detection Panels
    - 9.6.1.1.3. Adenovirus Detection Panels
    - 9.6.1.1.4. Sapovirus Detection Panels
    - 9.6.1.1.5. Other Viral Detection Panels
    - 9.6.1.1.6. Parasitic Detection Panels
    - 9.6.1.1.7. Clostridium difficile Detection Panels
    - 9.6.1.1.8. Other Detection Panels
  - 9.6.1.2. Sequencing Kits
- 9.6.2. Equipment
  - 9.6.2.1. Automated PCR Systems
  - 9.6.2.2. Sequencers
9.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
9.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 9.8.1. Hospitals
- 9.8.2. Clinics/Medical Centers
- 9.8.3. Diagnostic Laboratories
- 9.8.4. Research Institutes
9.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
9.10. Market Attractiveness Analysis
- 9.10.1. By Country
- 9.10.2. By Disease Strain Type
- 9.10.3. By Product
- 9.10.4. By End User
9.11. Market Attractiveness Analysis

10. Latin America Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Trends Analysis by Country, 2019-2023
- 10.3.1. Argentina
- 10.3.2. Brazil
- 10.3.3. Mexico
- 10.3.4. Rest of Latin America
10.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
10.5. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 10.5.1. Bacterial Strain
  - 10.5.1.1. Clostridium difficile
  - 10.5.1.2. E. coli
  - 10.5.1.3. Salmonella
  - 10.5.1.4. Staphylococcus aureus
  - 10.5.1.5. Campylobacter
  - 10.5.1.6. Other Bacterial Strains
- 10.5.2. Viral Strains
  - 10.5.2.1. Adenovirus
  - 10.5.2.2. Enterovirus
  - 10.5.2.3. Norovirus
  - 10.5.2.4. Rotavirus
  - 10.5.2.5. Sapovirus
  - 10.5.2.6. Other Viral Strains
- 10.5.3. Parasitic Strains
  - 10.5.3.1. Cryptosporidium parvum
  - 10.5.3.2. Giardia lamblia
  - 10.5.3.3. Other Parasitic Strains
10.6. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
10.7. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 10.7.1. Reagent Kits
  - 10.7.1.1. PCR Detection Panels
    - 10.7.1.1.1. Norovirus Detection Panels
    - 10.7.1.1.2. Rotavirus Detection Panels
    - 10.7.1.1.3. Adenovirus Detection Panels
    - 10.7.1.1.4. Sapovirus Detection Panels
    - 10.7.1.1.5. Other Viral Detection Panels
    - 10.7.1.1.6. Parasitic Detection Panels
    - 10.7.1.1.7. Clostridium difficile Detection Panels
    - 10.7.1.1.8. Other Detection Panels
  - 10.7.1.2. Sequencing Kits
- 10.7.2. Equipment
  - 10.7.2.1. Automated PCR Systems
  - 10.7.2.2. Sequencers
10.8. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
10.9. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 10.9.1. Hospitals
- 10.9.2. Clinics/Medical Centers
- 10.9.3. Diagnostic Laboratories
- 10.9.4. Research Institutes
10.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
10.11. Market Attractiveness Analysis
- 10.11.1. By Country
- 10.11.2. By Disease Strains Type
- 10.11.3. By Product
- 10.11.4. By End User
10.12. Market Attractiveness Analysis

11. Europe Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2018-2026

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
- 11.2.1. Germany
- 11.2.2. U.K.
- 11.2.3. France
- 11.2.4. Italy
- 11.2.5. Spain
- 11.2.6. Russia
- 11.2.7. Rest of Europe
11.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
11.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 11.4.1. Bacterial Strain
  - 11.4.1.1. Clostridium difficile
  - 11.4.1.2. E. coli
  - 11.4.1.3. Salmonella
  - 11.4.1.4. Staphylococcus aureus
  - 11.4.1.5. Campylobacter
  - 11.4.1.6. Other Bacterial Strains
- 11.4.2. Viral Strains
  - 11.4.2.1. Adenovirus
  - 11.4.2.2. Enterovirus
  - 11.4.2.3. Norovirus
  - 11.4.2.4. Rotavirus
  - 11.4.2.5. Sapovirus
  - 11.4.2.6. Other Viral Strains
- 11.4.3. Parasitic Strains
  - 11.4.3.1. Cryptosporidium parvum
  - 11.4.3.2. Giardia lamblia
  - 11.4.3.3. Other Parasitic Strains
11.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
11.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 11.6.1. Reagent Kits
  - 11.6.1.1. PCR Detection Panels
    - 11.6.1.1.1. Norovirus Detection Panels
    - 11.6.1.1.2. Rotavirus Detection Panels
    - 11.6.1.1.3. Adenovirus Detection Panels
    - 11.6.1.1.4. Sapovirus Detection Panels
    - 11.6.1.1.5. Other Viral Detection Panels
    - 11.6.1.1.6. Parasitic Detection Panels
    - 11.6.1.1.7. Clostridium difficile Detection Panels
    - 11.6.1.1.8. Other Detection Panels
  - 11.6.1.2. Sequencing Kits
- 11.6.2. Equipment
  - 11.6.2.1. Automated PCR Systems
  - 11.6.2.2. Sequencers
11.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
11.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 11.8.1. Hospitals
- 11.8.2. Clinics/Medical Centers
- 11.8.3. Diagnostic Laboratories
- 11.8.4. Research Institutes
11.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
11.10. Market Attractiveness Analysis
- 11.10.1. By Country
- 11.10.2. By Disease Strains Type
- 11.10.3. By Product
- 11.10.4. By End User
11.11. Market Attractiveness Analysis

12. Asia Pacific Excluding China Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
- 12.2.1. Japan
- 12.2.2. India
- 12.2.3. Australia and New Zealand
- 12.2.4. Rest of Asia Pacific Excluding China
12.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
12.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 12.4.1. Bacterial Strain
  - 12.4.1.1. Clostridium difficile
  - 12.4.1.2. E. coli
  - 12.4.1.3. Salmonella
  - 12.4.1.4. Staphylococcus aureus
  - 12.4.1.5. Campylobacter
  - 12.4.1.6. Other Bacterial Strains
- 12.4.2. Viral Strains
  - 12.4.2.1. Adenovirus
  - 12.4.2.2. Enterovirus
  - 12.4.2.3. Norovirus
  - 12.4.2.4. Rotavirus
  - 12.4.2.5. Sapovirus
  - 12.4.2.6. Other Viral Strains
- 12.4.3. Parasitic Strains
  - 12.4.3.1. Cryptosporidium parvum
  - 12.4.3.2. Giardia lamblia
  - 12.4.3.3. Other Parasitic Strains
12.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
12.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 12.6.1. Reagent Kits
  - 12.6.1.1. PCR Detection Panels
    - 12.6.1.1.1. Norovirus Detection Panels
    - 12.6.1.1.2. Rotavirus Detection Panels
    - 12.6.1.1.3. Adenovirus Detection Panels
    - 12.6.1.1.4. Sapovirus Detection Panels
    - 12.6.1.1.5. Other Viral Detection Panels
    - 12.6.1.1.6. Parasitic Detection Panels
    - 12.6.1.1.7. Clostridium difficile Detection Panels
    - 12.6.1.1.8. Other Detection Panels
  - 12.6.1.2. Sequencing Kits
- 12.6.2. Equipment
  - 12.6.2.1. Automated PCR Systems
  - 12.6.2.2. Sequencers
12.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
12.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 12.8.1. Hospitals
- 12.8.2. Clinics/Medical Centers
- 12.8.3. Diagnostic Laboratories
- 12.8.4. Research Institutes
12.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
12.10. Market Attractiveness Analysis
- 12.10.1. By Country
- 12.10.2. By Disease Strains Type
- 12.10.3. By Product
- 12.10.4. By End User
12.11. Market Attractiveness Analysis

13. China Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 13.2.1. Bacterial Strain
  - 13.2.1.1. Clostridium difficile
  - 13.2.1.2. E. coli
  - 13.2.1.3. Salmonella
  - 13.2.1.4. Staphylococcus aureus
  - 13.2.1.5. Campylobacter
  - 13.2.1.6. Other Bacterial Strains
- 13.2.2. Viral Strains
  - 13.2.2.1. Adenovirus
  - 13.2.2.2. Enterovirus
  - 13.2.2.3. Norovirus
  - 13.2.2.4. Rotavirus
  - 13.2.2.5. Sapovirus
  - 13.2.2.6. Other Viral Strains
- 13.2.3. Parasitic Strains
  - 13.2.3.1. Cryptosporidium parvum
  - 13.2.3.2. Giardia lamblia
  - 13.2.3.3. Other Parasitic Strains
13.3. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
13.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 13.4.1. Reagent Kits
  - 13.4.1.1. PCR Detection Panels
    - 13.4.1.1.1. Norovirus Detection Panels
    - 13.4.1.1.2. Rotavirus Detection Panels
    - 13.4.1.1.3. Adenovirus Detection Panels
    - 13.4.1.1.4. Sapovirus Detection Panels
    - 13.4.1.1.5. Other Viral Detection Panels
    - 13.4.1.1.6. Parasitic Detection Panels
    - 13.4.1.1.7. Clostridium difficile Detection Panels
    - 13.4.1.1.8. Other Detection Panels
  - 13.4.1.2. Sequencing Kits
- 13.4.2. Equipment
  - 13.4.2.1. Automated PCR Systems
  - 13.4.2.2. Sequencers
13.5. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
13.6. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 13.6.1. Hospitals
- 13.6.2. Clinics/Medical Centers
- 13.6.3. Diagnostic Laboratories
- 13.6.4. Research Institutes
13.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
13.8. Market Attractiveness Analysis
- 13.8.1. By Country
- 13.8.2. By Disease Strains Type
- 13.8.3. By Product
- 13.8.4. By End User
13.9. Market Attractiveness Analysis

14. Middle East & Africa Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
- 14.2.1. GCC Countries
- 14.2.2. South Africa
- 14.2.3. Rest of MEA
14.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
14.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
- 14.4.1. Bacterial Strain
  - 14.4.1.1. Clostridium difficile
  - 14.4.1.2. E. coli
  - 14.4.1.3. Salmonella
  - 14.4.1.4. Staphylococcus aureus
  - 14.4.1.5. Campylobacter
  - 14.4.1.6. Other Bacterial Strains
- 14.4.2. Viral Strains
  - 14.4.2.1. Adenovirus
  - 14.4.2.2. Enterovirus
  - 14.4.2.3. Norovirus
  - 14.4.2.4. Rotavirus
  - 14.4.2.5. Sapovirus
  - 14.4.2.6. Other Viral Strains
- 14.4.3. Parasitic Strains
  - 14.4.3.1. Cryptosporidium parvum
  - 14.4.3.2. Giardia lamblia
  - 14.4.3.3. Other Parasitic Strains
14.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
14.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
- 14.6.1. Reagent Kits
  - 14.6.1.1. PCR Detection Panels
    - 14.6.1.1.1. Norovirus Detection Panels
    - 14.6.1.1.2. Rotavirus Detection Panels
    - 14.6.1.1.3. Adenovirus Detection Panels
    - 14.6.1.1.4. Sapovirus Detection Panels
    - 14.6.1.1.5. Other Viral Detection Panels
    - 14.6.1.1.6. Parasitic Detection Panels
    - 14.6.1.1.7. Clostridium difficile Detection Panels
    - 14.6.1.1.8. Other Detection Panels
  - 14.6.1.2. Sequencing Kits
- 14.6.2. Equipment
  - 14.6.2.1. Automated PCR Systems
  - 14.6.2.2. Sequencers
14.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
14.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
- 14.8.1. Hospitals
- 14.8.2. Clinics/Medical Centers
- 14.8.3. Diagnostic Laboratories
- 14.8.4. Research Institutes
14.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
14.10. Market Attractiveness Analysis
- 14.10.1. By Country
- 14.10.2. By Disease Strains Type
- 14.10.3. By Product
- 14.10.4. By End User
14.11. Market Attractiveness Analysis

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

17.1. Market Structure Analysis
17.2. Market Share Analysis (2023), By Key Players

18. Competition Analysis

18.1. Becton, Dickinson and Company (BD)
- 18.1.1. Company Overview
- 18.1.2. Product Portfolio
- 18.1.3. Key Financials
- 18.1.4. Key Developments
18.2. Thermo Fisher Scientific Inc.
- 18.2.1. Company Overview
- 18.2.2. Product Portfolio
- 18.2.3. Key Financials
- 18.2.4. Key Developments
18.3. Bio-Rad Laboratories Inc.
- 18.3.1. Company Overview
- 18.3.2. Product Portfolio
- 18.3.3. Key Financials
- 18.3.4. Key Developments
18.4. Luminex Corporation
- 18.4.1. Company Overview
- 18.4.2. Product Portfolio
- 18.4.3. Key Financials
- 18.4.4. Key Developments
18.5. Hoffmann-La Roche Ltd.
- 18.5.1. Company Overview
- 18.5.2. Product Portfolio
- 18.5.3. Key Financials
- 18.5.4. Key Developments
18.6. bioMerieux SA
- 18.6.1. Company Overview
- 18.6.2. Product Portfolio
- 18.6.3. Key Financials
- 18.6.4. Key Developments
18.7. Quidel Corporation
- 18.7.1. Company Overview
- 18.7.2. Product Portfolio
- 18.7.3. Key Financials
- 18.7.4. Key Developments
18.8. Illumina, Inc.
- 18.8.1. Company Overview
- 18.8.2. Product Portfolio
- 18.8.3. Key Financials
- 18.8.4. Key Developments
18.9. Seegene Inc
- 18.9.1. Company Overview
- 18.9.2. Product Portfolio
- 18.9.3. Key Financials
- 18.9.4. Key Developments
18.10. Genetic Signatures
- 18.10.1. Company Overview
- 18.10.2. Product Portfolio
- 18.10.3. Key Financials
- 18.10.4. Key Developments